CATH Classification
Level | CATH Code | Description |
---|---|---|
3 | Alpha Beta | |
3.90 | Alpha-Beta Complex | |
3.90.180 | Quinone Oxidoreductase; Chain A, domain 1 | |
3.90.180.10 | Medium-chain alcohol dehydrogenases, catalytic domain |
Domain Context
CATH Clusters
Superfamily | Medium-chain alcohol dehydrogenases, catalytic domain |
Functional Family | Prostaglandin reductase 2 |
Enzyme Information
1.3.1.48 |
15-oxoprostaglandin 13-reductase.
based on mapping to UniProt Q14914
11-alpha-hydroxy-9,15-dioxoprost-5-enoate + NAD(P)(+) = (5Z)-(13E)-11- alpha-hydroxy-9,15-dioxoprosta-5,13-dienoate + NAD(P)H.
-!- Reduces 15-oxoprostaglandins to 13,14-dihydro derivatives. -!- The enzyme from placenta is specific for NAD(+).
|
1.3.1.74 |
2-alkenal reductase (NAD(P)(+)).
based on mapping to UniProt Q14914
A n-alkanal + NAD(P)(+) = an alk-2-enal + NAD(P)H.
-!- Highly specific for 4-hydroxynon-2-enal and non-2-enal. -!- Alk-2-enals of shorter chain have lower affinities. -!- Exhibits high activities also for alk-2-enones such as but-3-en-2-one and pent-3-en-2-one. -!- Inactive with cyclohex-2-en-1-one and 12-oxophytodienoic acid. -!- Involved in the detoxification of alpha,beta-unsaturated aldehydes and ketones (cf. EC 1.3.1.102).
|
1.3.1.- |
With NAD(+) or NADP(+) as acceptor.
based on mapping to UniProt Q14914
|
UniProtKB Entries (1)
Q14914 |
PTGR1_HUMAN
Homo sapiens
Prostaglandin reductase 1
|
PDB Structure
PDB | 2Y05 |
External Links | |
Method | X-RAY DIFFRACTION |
Organism | |
Primary Citation |
Crystal Structure of Human Leukotriene B4 12-Hydroxydehydrogenase in Complex with Nadp and Raloxifene
To be Published
|